PDCD1 and neoplasm: A clinical study compared the tumor immunophenotypes of patients with different NLRs and found that there were significantly higher numbers of CD8+ and PD-1+ immune cells and CD8+ and PD-1+ T cells infiltration into the tumor microenvironment along with a lower NLR (42).